# Effects of Rifampin on the Pharmacokinetics of Ataluren

> **NCT02409004** · PHASE1 · COMPLETED · sponsor: **PTC Therapeutics** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ataluren
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT02409004
- **Lead sponsor:** PTC Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02409004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02409004, "Effects of Rifampin on the Pharmacokinetics of Ataluren". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02409004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*